Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 0.316 | uM | 72 | hr | 3 | 17737 | 603 | 1.0777 | 1.0016 | 0.0340 | 0.0383 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 1 | 11677 | 368 | 0.7113 | 0.6866 | 0.0315 | 0.0312 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 2 | 10880 | 316 | 0.6645 | 0.6866 | 0.0290 | 0.0312 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 3 | 11246 | 370 | 0.6841 | 0.6866 | 0.0329 | 0.0312 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 1 | 5745 | 285 | 0.3434 | 0.2974 | 0.0496 | 0.0491 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 2 | 5681 | 246 | 0.3419 | 0.2974 | 0.0433 | 0.0491 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 3 | 3476 | 189 | 0.2068 | 0.2974 | 0.0544 | 0.0491 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 1 | 7134 | 125 | 0.4409 | 0.4477 | 0.0175 | 0.0178 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 2 | 7416 | 121 | 0.4589 | 0.4477 | 0.0163 | 0.0178 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 3 | 7190 | 141 | 0.4434 | 0.4477 | 0.0196 | 0.0178 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 0.316 | uM | 72 | hr | 1 | 5860 | 137 | 0.3600 | 0.3831 | 0.0234 | 0.0229 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 0.316 | uM | 72 | hr | 2 | 6306 | 150 | 0.3872 | 0.3831 | 0.0238 | 0.0229 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 0.316 | uM | 72 | hr | 3 | 6531 | 140 | 0.4020 | 0.3831 | 0.0214 | 0.0229 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 1.000 | uM | 72 | hr | 1 | 5187 | 137 | 0.3177 | 0.2831 | 0.0264 | 0.0325 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 1.000 | uM | 72 | hr | 2 | 5169 | 175 | 0.3141 | 0.2831 | 0.0339 | 0.0325 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 1.000 | uM | 72 | hr | 3 | 3592 | 134 | 0.2175 | 0.2831 | 0.0373 | 0.0325 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 3.160 | uM | 72 | hr | 1 | 3804 | 246 | 0.2238 | 0.1826 | 0.0647 | 0.0764 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 3.160 | uM | 72 | hr | 2 | 3262 | 246 | 0.1897 | 0.1826 | 0.0754 | 0.0764 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 3.160 | uM | 72 | hr | 3 | 2345 | 209 | 0.1344 | 0.1826 | 0.0891 | 0.0764 |
A-375 | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 1 | 3770 | 78 | 0.2322 | 0.2659 | 0.0207 | 0.0217 |
A-375 | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 2 | 4429 | 94 | 0.2727 | 0.2659 | 0.0212 | 0.0217 |
A-375 | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 3 | 4768 | 111 | 0.2929 | 0.2659 | 0.0233 | 0.0217 |
A-375 | Vemurafenib | JNK-IN-8 | 0.316 | 0.316 | uM | 72 | hr | 1 | 3156 | 117 | 0.1912 | 0.2100 | 0.0371 | 0.0374 |
A-375 | Vemurafenib | JNK-IN-8 | 0.316 | 0.316 | uM | 72 | hr | 2 | 3583 | 143 | 0.2164 | 0.2100 | 0.0399 | 0.0374 |
A-375 | Vemurafenib | JNK-IN-8 | 0.316 | 0.316 | uM | 72 | hr | 3 | 3667 | 129 | 0.2225 | 0.2100 | 0.0352 | 0.0374 |